Clinical trials of Melsmon: effects and contraindications
Clinical trials of Melsmon: effects and contraindications.
As a result of clinical studies, four large groups of medical effects recognized by Melsmon were recognized: an increase in oxygen absorption by tissues, an acceleration of tissue regeneration and healing, an increase in working capacity / relieving fatigue, and an improvement in blood clotting.
Clinical trials of Melsmon revealed the main side effects of the medicine - rash and redness (not established a direct connection with the components of the medicine ) in 0.5 - 5% of cases. Since an allergic reaction is possible and anaphylactic shock (not observed during the trials), the medicine should be used with caution. There are also general indicated contraindications for use during pregnancy and lactation.
Clinical studies of Melsmon in Japan.
Clinical trials of the medicine took place from the 1950s to the 1990s in Japan. Karasawa Yosuke (唐沢陽介), the leading medical researcher in Japan, devoted a number of articles to Melsmon and his effects in his studies - they are published in the Pharmacology and Treatment collections (薬理と治療9（3） 299 ～ 308、81) and also in "Basics and Clinical Trials" (基礎と臨床15（3） 661 ～ 670、1981). Dr. Tamura Toyoyuki (田村豊幸(タムラトヨユキ)) published a series of studies on Melsmon and its effects in the collection “Pharmacology and Treatment” (薬理（治療6（10)109～114、1978, as well as 田村豊幸ほか： 薬理治療 8 （1） 75 78、1980) in 1978 and 1890 The main work on the clinical and post-clinical trials was carried out by the scientific department of Melsmon Corporation.
Recent clinical studies of Melsmon in NIS and Russia.
In Russian, there are many clinical trials of Melsmon in gynecology (available here). Particular attention should be paid to the articles "Experience of using allogenic peptide medicine Melsmon in preparation for assisted reproduction programs" in science magazine Women's Consultation No 4 2016 (Silantyeva ES and others), where the reproductive possibilities of using the medicine are considered, the article "Innovations in Correction symptoms of climacteric syndrome: an experience of using placental hydrolyzate in perimenopausal women” in science magazine Gynecology. 2016; 18 (5) (Kovalenko I.I. and others), as well as this article - "Experience with the use of Melsmon placental injections in the correction of insomnia and other climacteric symptoms". These articles give a high score to the anti-aging effects of melmson and researchers expect melsmon to broaden the prospects for its use in near future. Studies mentioned above show that Melsmon medicine is effective for the following symptoms:
- menapause treatment
- general anti-aging therapy
- skin whitening procedures
- skin revitalization effect
- detox effect